Company Analysis China Medical System Holdings Limited
1. Summary
Advantages
- Price (0.9307 $) is less than fair price (1.43 $)
- Dividends (71.74%) are higher than the sector average (6.7%).
Disadvantages
- The stock's return over the last year (0%) is lower than the sector average (4.45%).
- Current debt level 7.34% has increased over 5 years from 6.21%.
- The company's current efficiency (ROE=15.47%) is lower than the sector average (ROE=131.98%)
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| China Medical System Holdings Limited | Financials | Index | |
|---|---|---|---|
| 7 days | 0% | 40.1% | -0.3% |
| 90 days | 0% | 39.9% | 5.3% |
| 1 year | 0% | 4.5% | 10.6% |
CHSYF vs Sector: China Medical System Holdings Limited has slightly underperformed the "Financials" sector by -4.45% over the past year.
CHSYF vs Market: China Medical System Holdings Limited has significantly underperformed the market by -10.56% over the past year.
Stable price: CHSYF is not significantly more volatile than the rest of the market on "OTC" over the last 3 months, with typical variations of +/- 5% per week.
Long period: CHSYF with weekly volatility of 0% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Below fair price: The current price (0.9307 $) is lower than the fair price (1.43 $).
Price significantly below the fair price: The current price (0.9307 $) is 53.6% lower than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (11.07) is lower than that of the sector as a whole (19.24).
P/E vs Market: The company's P/E (11.07) is lower than that of the market as a whole (59.87).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (1.71) is lower than that of the sector as a whole (1.73).
P/BV vs Market: The company's P/BV (1.71) is lower than that of the market as a whole (3.17).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (3.32) is higher than that of the sector as a whole (3.2).
P/S vs Market: The company's P/S indicator (3.32) is lower than that of the market as a whole (3.43).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (6.66) is lower than that of the sector as a whole (120.44).
EV/Ebitda vs Market: The company's EV/Ebitda (6.66) is lower than that of the market as a whole (40.12).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -1.02% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-1.02%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-6.77%).
5.4. ROE
ROE vs Sector: The company's ROE (15.47%) is lower than that of the sector as a whole (131.98%).
ROE vs Market: The company's ROE (15.47%) is lower than that of the market as a whole (41.73%).
5.5. ROA
ROA vs Sector: The company's ROA (13.54%) is lower than that of the sector as a whole (118.36%).
ROA vs Market: The company's ROA (13.54%) is lower than that of the market as a whole (29.55%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (22.76%) is higher than that of the sector as a whole (8.29%).
ROIC vs Market: The company's ROIC (22.76%) is higher than that of the market as a whole (10.99%).
7. Dividends
7.1. Dividend yield vs Market
High yield: The dividend yield of the company 71.74% is higher than the average for the sector '6.7%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 71.74% has been steadily paid over the past 7 years, DSI=0.79.
Weak dividend growth: The company's dividend yield 71.74% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (56.66%) are at a comfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
